NMRA Neumora Therapeutics, Inc.
Company Analysis
Latest News
🟢 Neumora Therapeutics is trading 5.5% up in after-hours trading
Neumora Therapeutics is trading at $0.50, up 5.53% after hours, with no clear catalyst identified. - Available news listings show no fresh company-specific...
🟢 Neumora Therapeutics is trading 10.73% up
Neumora Therapeutics is trading at $0.47, up 10.73%; the reason for the advance remains unclear. - No clear company-specific announcement or catalyst for the...
🟢 Neumora Therapeutics is trading 5.57% up
Neumora Therapeutics is trading 5.57% higher at $0.45, with no clear company-specific catalyst identified for the October 16 move. - It closed October 15 at...
🟢 Neumora Therapeutics is trading 6.5% up in pre-market
Neumora Therapeutics is trading at $0.45, up 6.46%, with no clear company-specific catalyst identified. - The provided price context shows a 20.45%...
🟢 Neumora Therapeutics is trading 5.4% up in after-hours trading
Neumora Therapeutics is trading 5.39% higher at $0.45 after hours, with no clear company-specific catalyst for the move. - Shares gained 20.45% in the regular...
🟢 Neumora Therapeutics is trading 19.38% up on October 15 with no clear catalyst
Neumora Therapeutics is trading at $0.42, up 19.38%, with no clear company-specific catalyst; biotech-sector strength may be contributing. - Biotech ETF XBI...
🟢 Neumora Therapeutics is trading 12.78% up in after-hours trading
Neumora Therapeutics is trading 12.78% up at $0.40 after-hours, with no clear company-specific catalyst identified. - The stock closed the October 14 regular...
🔴 Neumora Therapeutics is trading 10.67% down today amid broader pressure after hotter-than-expected inflation
Neumora Therapeutics is trading at $0.33, down 10.67%, as broader weakness followed hotter-than-expected inflation; no company-specific catalyst was identified...
🔴 Neumora Therapeutics is trading 5% down today as growth stocks face inflation and rate concerns
Neumora Therapeutics is trading 5.13% down at $0.35 on October 14, 2026, amid pressure on broader markets and biotech shares. Supplied market context points to...
🟢 Neumora Therapeutics is trading 8.37% up in pre-market
Neumora Therapeutics is trading 8.37% higher at $0.40 in pre-market; the reason for the move remains unclear. - Shares closed October 13 at $0.37 after falling...
🟢 Neumora Therapeutics is trading 7.75% up in after-hours trading — no clear catalyst reported
Neumora Therapeutics is trading 7.75% higher after hours at $0.40, following a regular-session close of $0.37 on October 13, 2026; no clear company-specific...
🔴 Neumora Therapeutics is trading 10.2% down
Neumora Therapeutics is trading at $0.39, down 10.15%. The available evidence does not identify a clear direct catalyst for the October 13 decline. - An...
🔴 Neumora Therapeutics is trading 6% down today
Neumora Therapeutics is trading at $0.41, down 5.58%; no confirmed company announcement explains the October 13 decline. - A report said Wall Street Zen...
🟢 Neumora Therapeutics is trading 7% up in pre-market as the reason remains unclear
Neumora Therapeutics is trading at $0.47, up 6.91%, with no confirmed explanation for its pre-market rise. - No confirmed company announcement explaining the...
🔴 Neumora Therapeutics is trading 5% down with no clear catalyst identified
Neumora Therapeutics is trading 5.02% lower at $0.45, with no confirmed catalyst identified. - No fresh company-specific announcement explaining the October...
🟢 Neumora Therapeutics is trading 5% up in pre-market
Neumora Therapeutics is trading 5% up at $0.50 in pre-market, but the reason for the increase remains unclear. - No fresh company-specific announcement...
🟢 Neumora Therapeutics rises 5.6% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🟢 Neumora Therapeutics is trading 11% up in pre-market
Neumora Therapeutics is trading 11.04% higher at $0.52 before the October 8, 2026 open, with no verified company-specific catalyst identified. - Shares closed...
🔴 Neumora Therapeutics is trading 7.6% down in pre-market with no verified catalyst identified
Neumora Therapeutics is trading at $0.43, down 7.64% in October 7 pre-market; no verified company-specific announcement explains the move. - Shares closed at...
🟢 Neumora Therapeutics is trading 5% up in after-hours trading
Neumora Therapeutics is trading 5.1% up at $0.49 after-hours on October 6, with no verified company-specific announcement identified to explain the move. -...